hypertension

AZ picks up $350m after selling hypertension drugs
Pharmaforum
Mon, 03/2/20 - 09:35 am
AstraZeneca
hypertension
Atnahs Pharma
After a brief break, AstraZeneca is back at divesting — handing off hypertension meds for $350M
Endpoints
Mon, 01/27/20 - 10:55 am
AstraZeneca
hypertension
Atnahs Pharma
[release] Duke University Researcher Calls for a ‘His and Hers’ Approach to Tackling Hypertension
CP WIre
Wed, 01/15/20 - 10:36 am
hypertension
Duke University
Women's Health
SIAM News
[release] Duke University Researcher Calls for a ‘His and Hers’ Approach to Tackling Hypertension
Wed, 01/15/20 - 10:34 am
hypertension
Duke University
Women's Health
SIAM News
Highlights: 2019 Cardiometabolic Health Congress, Chicago IL
CP Wire
Tue, 10/29/19 - 01:55 pm
cardiometabolic health
GLP-1 agonist
diabetes
lipids
hypertension
chronic kidney disease
heart failure
obesity
Highlights: 2019 Cardiometabolic Health Congress, Chicago IL
Tue, 10/29/19 - 01:54 pm
cardiometabolic health
GLP-1 agonist
diabetes
lipids
hypertension
chronic kidney disease
heart failure
obesity
FDA rejects Acer's rare disease drug, asks for new trial — shares crate
Endpoints
Wed, 06/26/19 - 10:11 am
Acer Therapeutics
celiprolol
hypertension
clinical trials
FDA
Ehlers-Danlos syndrome
Edsivo
Teva expands blood pressure drug recall in the US amid cancer fears
Pharmaforum
Fri, 06/14/19 - 10:08 am
Teva Pharmaceutical
losartan
product recalls
hypertension
Vifor Pharma’s hypertension and CKD drug Veltassa meets primary endpoint in phase II study
Pharmaceutical Business Review
Mon, 05/13/19 - 09:25 am
Vifor
hypertension
chronic kidney disease
Veltassa
clinical trials
FDA approves valsartan generic amid probe into impurities
Biopharma Dive
Fri, 03/15/19 - 09:18 am
FDA
hypertension
generics
Valsartan
A third cancer-causing impurity detected in U.S. supply of blood pressure drugs
Fierce Pharma
Mon, 03/4/19 - 07:46 pm
FDA
recalls
sartan
hypertension
How to stop a lack of diversity undermining clinical trial data
Financial Times
Sat, 01/19/19 - 06:31 pm
clinical trials
race
ethnicity
HIV
hypertension
cancer
Ablative Solutions Banks $77 Million in Series D Funding for Unique Approach to Treating Uncontrolled Hypertension
CP Wire
Thu, 01/3/19 - 04:09 pm
Ablative Solutions
hypertension
Ablative Solutions Banks $77 Million in Series D Funding for Unique Approach to Treating Uncontrolled Hypertension
Thu, 01/3/19 - 09:50 am
Ablative Solutions
hypertension
Renal Denervation: FDA Panel, Industry Mostly on the Same Page
MedPage
Sat, 12/8/18 - 12:24 pm
devices
renal denervation
FDA
hypertension
Blood Pressure Medication Recall: What Is In This That May Cause Cancer?
Forbes
Sun, 11/4/18 - 02:35 pm
hypertension
irbesartan
recalls
Amazon eyes chronic health market with Arcadia Group’s Choice health brand launch
Mass Device
Mon, 10/29/18 - 07:18 pm
Amazon
Arcadia
diabetes
hypertension
devices
Common Blood Pressure Medication Linked To Increased Risk Of Lung Cancer
Forbes
Sun, 10/28/18 - 07:45 pm
ARBs
lung cancer
hypertension
Adempas maker Bayer connects hypertension patients with new mentoring group
Fierce Pharma
Fri, 07/13/18 - 11:17 pm
Bayer
patients
drug marketing
hypertension
Adempas
Omada Health launches new programs for obesity-related diseases
Healthcare Dive
Fri, 06/22/18 - 07:52 pm
Omada Health
digital therapeutics
hypertension
diabetes
obesity

Pages